Metabolic rewiring drives resistance to targeted cancer therapy.
Jason W
JW
Locasale
D000970:Antineoplastic Agents / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods*; D006801:Humans; D000077341:Lapatinib; D011799:Quinazolines / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077341:Lapatinib